Arthritis, Rheumatoid
10 competing products in clinical development for Arthritis, Rheumatoid.
Pipeline by Phase
Phase 11
Phase 1/21
Phase 25
Phase 33
All Products (10)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Peficitinib | Astellas Pharma | Phase 3 | Completed | 40 |
| FKB327 + Humira® | Kyowa Kirin | Phase 3 | Completed | 40 |
| FKB327 + Humira® | Kyowa Kirin | Phase 3 | Completed | 40 |
| peficitinib | Astellas Pharma | Phase 2 | Completed | 35 |
| peficitinib + Placebo + methotrexate | Astellas Pharma | Phase 2 | Completed | 35 |
| peficitinib + Placebo | Astellas Pharma | Phase 2 | Completed | 35 |
| peficitinib + Placebo | Astellas Pharma | Phase 2 | Completed | 35 |
| E6011 | Eisai | Phase 1/2 | Completed | 32 |
| KPL-404 + Placebo | Kiniksa Pharmaceuticals | Phase 2 | Completed | 29 |
| Tilmanocept | Navidea Biopharmaceuticals | Phase 1 | Withdrawn | 11 |